Solutions

HTAnalyze supports organizations in critical market access, pricing, and value creation projects, combining clinical evidence, HEOR, assumed impact, and RWE into robust and actionable deliverables.

We operate extensively in the main decision-making bodies in Brazil, including Conitec, ANS, and CMED , and we have the technical capacity to meet international demands.

Market Access – Brazil

Conitec (SUS) Submissions

We develop submissions to Conitec with methodological rigor and complete deliverables, integrating clinical evidence, economic evaluation, and budgetary impact analysis for decisions within the SUS (Brazilian Public Health System).

Useful link and information

Public consultations: analysis and technical contributions

We support companies and institutions in building consistent contributions and responses, with a clear narrative, scientific backing, and strategic positioning.

Useful link and information

Preliminary assessment of submission feasibility

We assess the decision context and dossier maturity to guide the next strategic step: submit, strengthen the evidence package, or revise the market access strategy.

Useful link and information

ANS Submissions (List)

We structure dossiers and analyses for submissions to the ANS (Brazilian National Agency for Supplementary Health), with methodological rigor, clarity in the value proposition, and alignment with regulatory deadlines.

Useful link and information

CMED Price Dossier

We structure CMED price dossiers with technical and documentary consistency, integrating references, comparators, and justifications in accordance with regulations.

Useful link and information

Submission Support and Technical Defense

We provide comprehensive support throughout submission and technical defense processes, including dossier preparation, technical forms, presentation materials, strategic alignment, and preparation for interactions with decision-making committees.

Useful link and information